Philip has more than 20 years' experience writing about companies, general finance and investing matters for a variety of publications. His career has involved spells at the Investors Chronicle, where he was small companies and companies editor, Investors Week and most recently as editor of online financial news wire Sharecast. He has also contributed to a wide range of financial-focused publications on a freelance basis.
Midatech wants to demonstrate that Q-Octreotide can achieve safe and effective growth hormone levels while also highlighting the advantages of its release system
Physiomics' share price surged on a €500,000 contract for its virtual tumour software with Merck KgaA.
The study highlighted Allergy’s microcrystalline tyrosine (MCT) was a suitable and flexible alternative to aluminium hydroxide
Steve Harris, Circassia’s chief executive, said he expected to see strong revenue growth in 2018
Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group
Venture Life already manufactures numerous products for Alliance and the agreement confirms the extension of these arrangements to 31 December 2025.
The collaboration will see e-Therapeutics combine its Network-Driven Drug Discovery (NDD) platform with C4XD's Taxonomy3 technology
Securing a few key successful distribution channels will deliver robust revenue growth in 2018
Redx said today it has £13.6mln in the bank, which should last it into early 2019
In a £1bn deal, won against five other tenders, Morrison's will supply Safeway products and other national brands to 1,300 McColl's stores and 350 newsagents
British Telecom is developing a habit for unpleasant surprises